N/A N=150 Traditional vs Oral Fluid Management in Total Knee Arthroplasty
Arthroplasty, Replacement, Knee
Primary: Body Weight — -1.9; -1.6 pounds
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=134 Facebook and Friends: Developing an Effective Online Social Network for Weight Loss
Weight Loss
Primary: Engagement — 77.00; 116.50; 46.0 Total Engagements — p=0.72
N/A N=421 Rheumatoid Arthritis Satisfaction Outcome Research
Rheumatoid Arthritis
Primary: Treatment Satisfaction Questionnaire for Medication (TSQM) Version 1.4 — 62.271; 64.191; 93.390; 96.603 units on a scale — p=0.3648
N/A N=44 Low Dose Thymoglobin in Renal Transplant Patients
Acute Renal Failure
Primary: Rates of Acute Cellular Rejection Between Study Group — 4; 2 Number of rejection — p=<0.05
N/A N=40 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation
Chronic Pain
Primary: Numeric Rating Scale (Pain) — 5.2; 5.2; 5.3 units on a scale
N/A N=21,664 Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)
Pre-diabetes
Primary: Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke — 1.100; 1.096 units on a scale — p=<0.05
N/A N=67 Epidemiology Non-cholera Vibrio Infections
Vibrio Infections
Primary: Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection — 20; 7; 2; 18 Participants
Phase 2 N=72 A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
Palmar Hyperhidrosis
Primary: Mean Change From Baseline to Week 2 in Hand Sweating Severity Score — -2.14; -0.56; -1.64; -3.03 score on a scale — p=0.244
Phase 2 N=1 The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
Clostridium Difficile Infection · C.Difficile Diarrhea · CDI
Primary: Assess Efficacy of Oral FMT on Composition and Function of the Gut Microbiota Compared to Placebo.
N/A N=101 Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)
Coronary Artery Disease
Primary: Percent of Participants With Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as Accurate and Appropriate — 101; 31…
Phase 3 N=278 A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
Major Depressive Disorder
Primary: Change From Baseline to the End of Treatment (EOT) in the Montgomery Asberg Depression Rating Scale-10 (MADRS-10) Scores — -11.4; -13.9; -4.2; -4.7 score on a scale…
N/A N=7 Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Analgesia
Postoperative Pain
Primary: Change From Baseline of Surgical Site Pain Level (NRS) at Rest [Percentage of Baseline Pain] — 64; 100; 55; 69 percentage of baseline
Phase 3 N=228 Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Ulcerative Colitis
Primary: Proportion of Subjects With Remission — 19; 13 Participants — p=>0.05
Phase 2 N=12 An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
Atopic Dermatitis
Primary: % Change From Baseline in Total IgE — -45.57 percentage change
Phase 1 N=24 IDH1 Peptide Vaccine for Recurrent Grade II Glioma
Brain Cancer · Brain Neoplasm, Primary · Brain Neoplasms, Recurrent
Primary: Percentage of Participants With an Unacceptable Toxicity — 0 percentage of participants